ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Wistar’s Koprowski; Rivera Is Director

April 12, 1991

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

In Brief: Reviewed CCOP Applications Won’t Be Funded; Potter Recruiting For New Medical Oncology Chief

September 30, 1983

Komen, Baylr, UT Southwestern Form Alliance

November 13, 1987